pharmathene inc (PIP:NYSE Amex)
John A. T. Young Ph.D.
Member of Scientific Advisory Board, PharmAthene, Inc.
|Age||Total Calculated Compensation||This person is connected to 46 board members in 2 different organizations across 1 different industries.|
See Board Relationships
John A. T. Young Ph.D. is a Professor at The Salk Institute of Biological studies in La Jolla, CA. Dr. Young served as Howard M. Temin professor in Cancer research at the McArdele Laboratory of Cancer Research University of Wisconsin. He served as Chairman of CMB Graduate program. He serves as Member of the Board of Directors of Salk Institute for Biological Studies. He also serves as a Member Of Scientific Advisory Board of Pharmathene, Inc.
One Park PlacePhone: 410-269-2600
Annapolis, Maryland 21401
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|David Aviezer Ph.D., M.B.A.||Chief Executive Officer, President, Executive Director and Chief Executive Officer of Protalix Ltd|
Protalix BioTherapeutics, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|